Retinal Dystrophy Due to Biallelic ABCA4 Mutations
1 clinical trials · Condition
◉ Watch Retinal Dystrophy Due to Biallelic ABCA4 Mutations
| Record | Firm | Date |
|---|---|---|
| Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease) (NCT07002398) | VeonGen Therapeutics GmbH | 2024-12-23 |
Track Retinal Dystrophy Due to Biallelic ABCA4 Mutations automatically
Every clearance here is in the API, with alerts when new ones post.